Boost for breast MRI, as trial shows improved diagnosis rates
This article was originally published in Clinica
Breast MRI in women already diagnosed with cancer in one breast can detect over 90% of tumours that are missed by mammography and clinical breast examination in the opposite (contralateral) breast, according to a study published in the March 29 issue of The New England Journal of Medicine (NEJM).
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.